A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme

Cancer Investigation

Volumn 18, Issue 6, 2000, Pages 510-515

  Reni, Michele ^a   Cozzarini, Cesare ^b   Ferreri, Andrés J M ^b   Ceresoli, Giovanni L ^b   Galli, Laura ^a   Bianchi, Alessandra ^b   Villa, Eugenio ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b San Raffaele Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; LOMUSTINE; NITROSOUREA DERIVATIVE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TUMOR BIOPSY;

EID: 0033943967     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012189     Document Type: Article

References (30)

1. Fine HA, Dear KBG, Loeffler JS, et al: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993.
2. Chang CH, Horton J, Schoenfeld D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997-1007, 1993.
3. Chang SM, Prados MD: Chemotherapy for gliomas. Curr Opin Oncol 7:207-213, 1995.
4. Brada M, Sharpe G: Chemotherapy of high-grade gliomas: beginning of a new era or the end of the old. Eur J Cancer 32A:2193-2194. 1996.
5. Curran WJ, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704-710. 1993.
6. Scott CB, Scarantino C, Urtasun R, et al: Validation and predictive power of radiation therapy oncology group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radial Oncol Biol Phys 40:51-55, 1998.
7. Kaplan EL, Meier P: Non-parametric estimations from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
8. Peto R. Pike MC: Conservatism of the approximation (O-E)/E in the log rank test for survival data or tumor incidence data. Biometrics 29:579-583, 1973.
9. Cox DR: Regression models and life-tables. J R Stat Soc 34:187-220, 1972.
10. Miller PJ, Hassanein RS, Giri PGS, et al: Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys 19:275-280, 1990.
11. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980.
12. Sheline GE: Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys 18:793-803, 1990.
13. Leibel SA, Scott CB, Loeffler JS: Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 21:198-219, 1994.
14. Medical Research Council Brain Tumor Working Party: A Medical Research Council trial of two radiotherapy doses in the treatment of grade 3 and 4 astrocytoma. Br J Cancer 64:769-774, 1991.
15. Salminen E, Nuutinen JM, Huhtala S: Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer 32A:1918-1923, 1996.
16. Kelly KA, Kirkwood JM, Kapp DS: Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat Rev 11:1-26, 1984.
17. Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762-766, 1993.
18. Vecht CJ, Avezaat CJJ, van Putten WLJ, et al: The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53:466-471, 1990.
19. Berger M: Malignant astrocytomas: surgical aspects. Semin Oncol 21:172-185, 1994.
20. Catteral M, Bloom HJG, Ash DV, et al: Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. Int J Radiat Oncol Biol Phys 6:261-266, 1980.
21. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731, 1979.
22. Shihamoto Y, Yamashita J, Takahashi M, et al: Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 18:9-17, 1990.
23. Nelson DF, Diener-West M, Horton J, et al: Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. Natl Cancer Inst Monogr 6:279-284, 1988.
24. Daumas-Duport C, Tucker ML, Kolles H, et al: Oligodendrogliomas. Part II. A new grading system based on morphological and imaging criteria. J Neurooncol 34:61-78, 1997.
25. Stenning SP, Freedman LS, Bleehen NM: An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer 56:89-90, 1987.
26. EORTC. Evaluation of CCNU. VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. J Neurosurg 55:27-31, 1981.
27. Thomas DGT, Bleehen NM, Roberts JT, et al: MRC randomized trial of adjuvant chemotherapy in high grade glioma (HGG)-BR05. J Neurooncol 39:102, 1998.
28. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993.
29. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest 14:551-559, 1996.
30. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68:1-17, 1988.